TY  - GEN
AU  - Chen,Rui
AU  - Zhou,Li-Qun
AU  - Cai,Xiao-Bing
AU  - Xie,Li-Ping
AU  - Huang,Yi-Ran
AU  - He,Da-Lin
AU  - Gao,Xu
AU  - Xu,Chuan-Liang
AU  - Ding,Qiang
AU  - Wei,Qiang
AU  - Yin,Chang-Jun
AU  - Ren,Shan-Cheng
AU  - Wang,Fu-Bo
AU  - Tian,Ye
AU  - Sun,Zhong-Quan
AU  - Fu,Qiang
AU  - Ma,Lu-Lin
AU  - Zheng,Jun-Hua
AU  - Ye,Zhang-Qun
AU  - Ye,Ding-Wei
AU  - Xu,Dan-Feng
AU  - Hou,Jian-Quan
AU  - Xu,Ke-Xin
AU  - Yuan,Jian-Lin
AU  - Gao,Xin
AU  - Liu,Chun-Xiao
AU  - Pan,Tie-Jun
AU  - Sun,Ying-Hao
TI  - Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1)
SN  - 1745-7262
PY  - 2016///0809
KW  - Aged
KW  - Asian People
KW  - Biomarkers, Tumor
KW  - blood
KW  - Biopsy, Large-Core Needle
KW  - Carcinoma
KW  - China
KW  - Digital Rectal Examination
KW  - Endosonography
KW  - Humans
KW  - Image-Guided Biopsy
KW  - Kallikreins
KW  - Male
KW  - Middle Aged
KW  - Organ Size
KW  - Prostate
KW  - pathology
KW  - Prostate-Specific Antigen
KW  - Prostatic Neoplasms
KW  - ROC Curve
KW  - Retrospective Studies
KW  - Sensitivity and Specificity
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4103/1008-682X.150846
ER  -